s-plus version 7.0 (TIBCO)
TIBCO is a verified supplier 
90
Structured Review
TIBCO
s-plus version 7.0
S Plus Version 7.0, supplied by TIBCO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s-plus+version+7%2E0/8+0+statistical+package/pm28806561-55-16-19
Average 90 stars, based on 1 article reviews
S Plus Version 7.0, supplied by TIBCO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s-plus+version+7%2E0/8+0+statistical+package/pm28806561-55-16-19
Average 90 stars, based on 1 article reviews
s-plus version 7.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Out-of-Hospital Hypertonic Resuscitation Following Severe Traumatic Brain Injury: A Randomized Controlled Trial Article Snippet: Analyses were performed using SAS version 9.2 (SAS Institute Inc, Cary, North Carolina) and Article Title: Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer. Article Snippet: Results One hundred and seventeen patients with advanced malignancies were enrolled.. Neutropenia was the primary dose-limiting toxicity.. Prophylactic pegfilgrastim reduced neutropenia frequency and severity, allowing administration of higher litronesib doses, but increases in the incidences of mucositis and stomatitis were observed. Article Title: Delirium and exposure to psychoactive medications in critically ill adults: A multi-centre observational study. Article Snippet: Delirium and exposure to psychoactive medications in critically ill adults: A multi-centre observational study Lisa D. Burry, David R. Williamson, Sangeeta Mehta, Marc M. Perreault, Ioanna Mantas, Ranjeeta Mallick, Dean A. Fergusson, Orla Smith, Eddy Fan, Sebastien Dupuis, Margaret Herridge, Louise Rose PII: S0883-9441(17)30313-1 DOI: doi: 10.1016/j.jcrc.2017.08.003 Reference: YJCRC 52628 To appear in: Revised date: ###REVISEDDATE### Accepted date: ###ACCEPTEDDATE### Please cite this article as: Lisa D. Burry, David R. Williamson, Sangeeta Mehta, Marc M. Perreault, Ioanna Mantas, Ranjeeta Mallick, Dean A. Fergusson, Orla Smith, Eddy Fan, Sebastien Dupuis, Margaret Herridge, Louise Rose , Delirium and exposure to psychoactive medications in critically ill adults: A multi-centre observational study, (2017), doi: 10.1016/j.jcrc.2017.08.003 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Article Title: A population-based study of emergency department presentations for asthma in regions of Alberta. Article Snippet: SAS (version 9.1, SAS Institute Inc.) and Article Title: Transcriptome analysis of ageing in uninjured human Achilles tendon Article Snippet: The analyses were undertaken by using edgeR [ ], Article Title: Acceptability of Intanza® 15 μg intradermal influenza vaccine in Belgium during the 2010-2011 influenza season. Article Snippet: Introduction: Intradermal (ID) influenza vaccination induces an enhanced immune response in the elderly when compared with intramuscular (IM) vaccination.. In 2009, an ID seasonal influenza vaccine (Intanza® [Sanofi Pasteur MSD, Lyon, France] 15 μg) was approved for use in individuals aged ≥ 60 years in Europe.. This survey conducted in Belgium was the first in Europe to assess the acceptability of this vaccine in routine clinical practice by vaccinees and their general practitioners (GPs). Article Title: Higher mortality among remote compared to rural or urban dwelling hemodialysis patients in the United States. Article Snippet: Analyses were performed with SAS version 9.1 (SAS Institute, Cary, NC) and Article Title: Prevalence, risk factors, and outcomes associated with physical restraint use in mechanically ventilated adults. Article Snippet: ☆ Conflict of interest: The authors have no conflicts of i ☆☆ ClinicalTrials.gov NCT 00675363.. ★ Funding: The SLEAP trial was funded by the Canadian Nurses and a Sigma Theta Tau International Lambda Pi-At ⁎ Corresponding author at: Mount Sinai Hospital, 600 U E-mail address: Geeta.mehta@utoronto.ca (S. Mehta). http://dx.doi.org/10.1016/j.jcrc.2015.09.011 0883-9441/© 2015 Elsevier Inc. All rights reserved. |